-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lipella Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q2 2024.
- Lipella Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $14K, a 61.5% decline year-over-year.
- Lipella Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $114K, a 140% increase year-over-year.
- Lipella Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was $127K.
- Lipella Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was -$7.98K, a 116% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)